BRIEF-Auxilium expects to submit supplemental biologics license application for Xiaflex to FDA in Q1
November 18, 2013 at 07:26 AM EST
Nov 18 (Reuters) - Auxilium Pharmaceuticals Inc : * Announces results of the xiaflex in dupuytren's multicord contracture trial * Says expects to submit supplemental biologics license application to FDA in
